首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1471985

主动脉覆膜支架市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、最终用户和地理位置

Aortic Stent Grafts Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography

出版日期: 2024年03月07日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

主动脉覆膜支架市场预计将从2023年的24.9亿美元成长到2031年的40.3亿美元；预计 2023 年至 2031 年市场复合年增长率为 6.2%。

推动市场成长的关键因素是主动脉瘤发生率的增加以及对血管内修復等微创手术的需求不断增长。然而，市场参与者发起的产品召回阻碍了市场的成长。此外，製造商的技术进步和策略活动预计将在未来几年带来新的主动脉覆膜支架市场趋势。

主动脉覆膜支架市场的市场驱动因素与限制

主动脉瘤盛行率的上升促进了主动脉覆膜支架市场的成长。根据爱思唯尔 2021 年 3 月发表的文章，已开发国家有 2% 至 8% 的人患有腹主动脉瘤（AAA）。如果不及时治疗，它可能会发展为危及生命的破裂，死亡率高达 80%。主动脉覆膜支架是主动脉瘤血管内修復的重要组成部分。根据英国国家医疗服务体系 (NHS) AAA 筛检计画于 2022 年 4 月发布的 2020 年至 2021 年 AAA 标准报告，约 210,800 名男性接受了筛检，期间发现了 1,542 例动脉瘤病例。在发现动脉瘤的患者中，88.8%的适合择期修復的患者接受了手术。肥胖、吸烟和久坐的生活方式是这种心血管疾病的危险因子。老年人更容易患心血管疾病，包括主动脉瘤，因此他们经常需要血管内动脉瘤修復（EVAR）手术。主动脉覆膜支架主要用于这些手术，因为与传统的开放性修復手术相比，它具有减少住院和 ICU 住院时间以及失血量等优点。因此，主动脉瘤手术数量的增加推动了主动脉覆膜支架市场的成长。

然而，主动脉支架移植市场不断增加的产品召回引起了医疗保健提供者和患者的担忧。这些召回可能是由于设计缺陷、製造缺陷或安全标准不足造成的。主动脉支架移植市场主要参与者回想的一些产品如下：

2023 年 5 月，Terumo Aortic 主动召回特定批次的 Terumo Aortic TREO 腹部覆膜支架系统，原因是移植物尺寸不正确的潜在问题。

2021 年 2 月，由于支架断裂和 III 型内漏的风险，美敦力召回了其未使用的 Valiant Navion 胸腔覆膜支架系统。

2020 年 5 月，Endologix Inc. 宣布召回其 Ovation iX 产品，因为植入过程中存在液体聚合物洩漏的风险。该公司表示，大多数聚合物洩漏的根本原因是製造过程中的材料缺陷。

由于产品召回，对某些品牌和产品的信任可能会减弱，从而导致对主动脉瓣置换装置的需求可能下降。此外，患者和医疗专业人员在考虑这些设备时可能会变得格外谨慎，更愿意选择替代方案或延迟手术。因此，产品召回的增加阻碍了主动脉覆膜支架市场的成长。

主动脉覆膜支架市场：细分概述

主动脉覆膜支架市场根据产品和最终用户进行细分。依产品划分，市场分为腹主动脉覆膜支架及胸主动脉覆膜支架。 2023年，腹主动脉覆膜支架细分市场将占据更大的市场份额。这种覆膜支架被植入患者的腹主动脉内，以帮助保护动脉瘤免于破裂。 AAA 病例的增加以及对微创手术治疗的需求不断增长正在推动市场对这些覆膜支架的需求。

就最终用户而言，主动脉覆膜支架市场分为医院和门诊手术中心。由于专业且复杂的科学仪器的存在，预计医院领域将在 2023 年至 2031 年期间占据重要的市场份额。这些组织僱用了受过现代医学科学问题教育的训练有素的工作人员团队。他们透过为患有各种疾病的患者提供广泛的医疗服务而发挥着重要作用。因此，医院是主动脉覆膜支架装置的主要最终用户，因为它们提供广泛的医疗服务，包括 EVAR 和胸主动脉血管内修復 (TEVAR) 等侵入性手术。

主动脉覆膜支架市场：地理概况

全球近距离治疗设备市场报告的范围涵盖北美（美国、加拿大和墨西哥）、欧洲（德国、法国、义大利、英国、西班牙和欧洲其他地区）、亚太地区（中国、日本、印度）、澳洲、韩国以及亚太其他地区）、中东和非洲（南非、沙乌地阿拉伯、阿联酋以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地区）。 2023年，北美占据主动脉覆膜支架主要市场份额，其次是欧洲；亚太地区的市场在预测期内以最高的复合年增长率成长。该地区主动脉覆膜支架市场的成长归因于该地区主动脉瘤发生率及其危险因子的上升。

欧洲
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 欧洲其他地区
亚太
- 澳洲
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 10 章：产业格局

併购
协议、合作、合资企业
新产品发布
扩张和其他策略发展

第 11 章：竞争格局

关键参与者的热图分析
公司定位与专注

第 12 章：主动脉覆膜支架市场 - 主要公司概况

Endologix Inc
Terumo Corporation
Radcliffe Medical Media
MicroPort Scientific Corporation
Corcym
LeMaitre Vascular, Inc
W. L. Gore & Associates, Inc
JOTEC GmbH
Medtronic

第 13 章：附录

简介目录

Product Code: TIPHE100000878

The aortic stent grafts market is projected to grow from US$ 2.49 billion in 2023 to US$ 4.03 billion by 2031; the market is estimated to record a CAGR of 6.2% during 2023-2031.

Key factors driving the market growth are the increasing incidence of aortic aneurysms and the rising demand for minimally invasive procedures such as endovascular repairs. However, product recalls initiated by the market players hinder the market growth. Furthermore, technological advancements and strategic activities by the manufacturers are expected to bring new aortic stent grafts market trends in the coming years.

Market Drivers and Restraints of the Aortic Stent Grafts Market

The rising prevalence of aortic aneurysms contributes to the aortic stent grafts market growth. According to the article published by Elsevier in March 2021, abdominal aortic aneurysms (AAA) are found in 2% to 8% of people in developed countries. It can progress to life-threatening rupture, with mortality rates as high as 80% if left untreated. Aortic stent grafts are a critical component of endovascular repair of aortic aneurysms. According to the AAA standards report 2020 to 2021 published by the National Health Service (NHS) AAA screening program in April 2022, ~210,800 men were offered screening, during which 1,542 aneurysms cases were detected. Among the patients detected with aneurysms, 88.8% who were suitable for elective repair underwent the procedure. Obesity, smoking, and a sedentary lifestyle are among the risk factors for this cardiovascular condition. The geriatric population is more vulnerable to developing cardiovascular diseases, including aortic aneurysms, owing to which they often require endovascular aneurysm repair (EVAR) surgeries. Aortic stent grafts are majorly used in these surgeries owing to their advantages, such as reduced hospital and ICU stay and blood loss, over traditional open repair surgeries. Therefore, the high number of surgeries for aortic aneurysms drives the aortic stent grafts market growth.

However, increasing product recalls in the aortic stent graft market have raised concerns among healthcare providers and patients. These recalls can be due to design flaws, manufacturing defects, or inadequate safety standards. A few product recalls by the key players in the aortic stent graft market are mentioned below:

In May 2023, Terumo Aortic issued a voluntary recall of specific lots of the Terumo Aortic TREO Abdominal Stent-Graft Systems due to the potential issue of having an incorrectly sized graft.

In February 2021, Medtronic recalled its unused Valiant Navion thoracic stent graft system due to a risk of stent fractures and Type III endoleaks.

In May 2020, Endologix Inc. announced a recall of its Ovation iX product due to the risk of liquid polymer leaks during implantation. The company stated that the root cause of most polymer leaks was a material weakness during manufacturing.

As a result of product recalls, trust in certain brands and products may diminish, leading to a potential decline in demand for aortic valve replacement devices. In addition, patients and medical professionals may become extra cautious when considering these devices, preferring to opt for alternatives or delaying procedures. Thus, an increase in product recalls hampers the aortic stent grafts market growth.

Aortic Stent Grafts Market: Segmental Overview

The aortic stent grafts market is segmented on the basis of product and end user. By product, the market is bifurcated into abdominal aortic stent grafts and thoracic aortic stent grafts. The abdominal aortic stent graft segment held a larger market share in 2023. Abdominal aortic stent grafts are medical devices utilized in EVAR to treat aortic aneurysms of the abdomen. This stent graft is implanted inside the abdominal aorta of the patient to help protect the aneurysm from rupturing. Increasing cases of AAA and the rising demand for minimally invasive surgery for treatment are boosting the demand for these stent-grafts in the market.

In terms of end users, the aortic stent grafts market is segmented into hospitals and ambulatory surgical centers. The hospital segment is anticipated to hold a significant market share during 2023-2031, owing to the presence of specialized and complex scientific instruments. These organizations employ teams of trained staff educated in the problems of modern medical science. They serve a significant role by providing extensive medical services to patients with various diseases. Therefore, hospitals are the primary end users of aortic stent graft devices as they offer a wide range of medical services, including invasive procedures such as EVAR and thoracic endovascular aortic repair (TEVAR).

Aortic Stent Grafts Market: Geographical Overview

The scope of the global brachytherapy devices market report entails North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America held a major aortic stent grafts market share in 2023, followed by Europe; the market in the Asia Pacific region is growing with the highest CAGR during the forecast period. The growth of the aortic stent grafts market in this region is attributed to the rising incidence of aortic aneurysm and its risk factors in the region.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Aortic Stent Grafts Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Aortic Stent Grafts Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Aortic Stent Grafts Market - Global Market Analysis

6.1 Aortic Stent Grafts - Global Market Overview
6.2 Aortic Stent Grafts - Global Market and Forecast to 2031

7. Aortic Stent Grafts Market - Revenue Analysis (USD Million) - By Product, 2021-2031

7.1 Overview
7.2 Abdominal Aortic Stent Grafts
7.3 Thoracic Aortic Stent Grafts

8. Aortic Stent Grafts Market - Revenue Analysis (USD Million) - By End User, 2021-2031

8.1 Overview
8.2 Hospitals
8.3 Ambulatory Surgical Centers

9. Aortic Stent Grafts Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

9.1 North America
- 9.1.1 North America Aortic Stent Grafts Market Overview
- 9.1.2 North America Aortic Stent Grafts Market Revenue and Forecasts to 2031
- 9.1.3 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By Product
- 9.1.4 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By End User
- 9.1.5 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By Countries
  - 9.1.5.1 United States Aortic Stent Grafts Market
    - 9.1.5.1.1 United States Aortic Stent Grafts Market, by Product
    - 9.1.5.1.2 United States Aortic Stent Grafts Market, by End User
  - 9.1.5.2 Canada Aortic Stent Grafts Market
    - 9.1.5.2.1 Canada Aortic Stent Grafts Market, by Product
    - 9.1.5.2.2 Canada Aortic Stent Grafts Market, by End User
  - 9.1.5.3 Mexico Aortic Stent Grafts Market
    - 9.1.5.3.1 Mexico Aortic Stent Grafts Market, by Product
    - 9.1.5.3.2 Mexico Aortic Stent Grafts Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

9.2 Europe
- 9.2.1 Germany
- 9.2.2 France
- 9.2.3 Italy
- 9.2.4 Spain
- 9.2.5 United Kingdom
- 9.2.6 Rest of Europe
9.3 Asia-Pacific
- 9.3.1 Australia
- 9.3.2 China
- 9.3.3 India
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
9.4 Middle East and Africa
- 9.4.1 South Africa
- 9.4.2 Saudi Arabia
- 9.4.3 U.A.E
- 9.4.4 Rest of Middle East and Africa
9.5 South and Central America
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Rest of South and Central America

10. Industry Landscape

10.1 Mergers and Acquisitions
10.2 Agreements, Collaborations, Joint Ventures
10.3 New Product Launches
10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Positioning and Concentration

12. Aortic Stent Grafts Market - Key Company Profiles

12.1 Endologix Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments

Note - Similar information would be provided for below list of companies